Home/Filings/4/0000950170-24-056086
4//SEC Filing

D'Andrea Carrie 4

Accession 0000950170-24-056086

CIK 0001444192other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 7:19 PM ET

Size

5.2 KB

Accession

0000950170-24-056086

Insider Transaction Report

Form 4
Period: 2024-05-06
D'Andrea Carrie
VP Clinical Operations
Transactions
  • Award

    Stock Options (Right to Buy)

    2024-05-06+19,74019,740 total
    Exercise: $2.96Exp: 2034-05-06Class A Common Shares (19,740 underlying)
Footnotes (1)
  • [F1]Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.

Documents

1 file

Issuer

Acasti Pharma Inc.

CIK 0001444192

Entity typeother

Related Parties

1
  • filerCIK 0001977969

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:19 PM ET
Size
5.2 KB